Alejandro González Veliz: Most Reported Aspirin Allergies Are Not True Hypersensitivity
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about recent article by Silvia Grimaldi et al., published in European Heart Journal, adding:
“Aspirin remains one of the most important drugs in cardiovascular medicine.
Yet many patients arrive with a history of ‘aspirin allergy,’ often leading clinicians to avoid a therapy that may be crucial after PCI, ACS, or valve interventions.
The reality?
Most reported reactions are not true hypersensitivity.
A careful history can distinguish intolerance from genuine allergy, and for selected patients, aspirin desensitization can safely restore access to guideline-directed therapy.
Understanding this distinction may prevent treatment delays, suboptimal antiplatelet strategies, and potentially avoidable cardiovascular events.”
Title: Aspirin hypersensitivity: a practical guide for cardiologists
Authors: Silvia Grimaldi, Paola Migliorini, Ilaria Puxeddu, Roberta Rossini, Raffaele De Caterina
Other posts featuring Alejandro González Veliz on Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?